NexgenRx Inc. (TSXV:NXG)
0.360
0.00 (0.00%)
At close: Apr 27, 2026
NexgenRx Revenue
In the year 2025, NexgenRx had annual revenue of 17.93M CAD with 8.84% growth. NexgenRx had revenue of 4.42M in the quarter ending December 31, 2025, with 5.21% growth.
Revenue
17.93M
Revenue Growth
+8.84%
P/S Ratio
1.43
Revenue / Employee
896.62K
Employees
20
Market Cap
25.60M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 17.93M | 1.46M | 8.84% |
| Dec 31, 2024 | 16.48M | 2.63M | 18.99% |
| Dec 31, 2023 | 13.85M | 1.07M | 8.33% |
| Dec 31, 2022 | 12.78M | 939.94K | 7.94% |
| Dec 31, 2021 | 11.84M | 1.27M | 12.01% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Principal Technologies | 370.42K |
| DIAGNOS | 68.16K |
| Comprehensive Healthcare Systems | 5.79M |
| AI/ML Innovations | 125.47K |
| NetraMark Holdings | 165.26K |
| Seegnal | 1.72M |
| nDatalyze | 887.00 |
NexgenRx News
- 11 days ago - NexgenRx Announces Declaration of Divdend - Accesswire
- 4 weeks ago - NexgenRx Announces 2025 Year End Results with Continued Increasing Net Income, EBITDA And Revenue Growth - Accesswire
- 4 months ago - NexgenRx Announces Declaration of Divdends - Accesswire
- 4 months ago - NexgenRx Announces Declaration of Dividends - Accesswire
- 5 months ago - NexgenRx Announces Significant Third Quarter Revenue and EBITDA Growth - Accesswire
- 9 months ago - NexgenRx Announces Declaration of Dividend - Accesswire
- 9 months ago - NexgenRx Announces Second Quarter Results with Significant Revenue Growth and Positive EBITDA - Accesswire
- 1 year ago - NexgenRx Announces First Quarter Results With Solid Revenue Growth and Positive EBITDA - Accesswire